Prelude Capital Management, LLC Horizon Therapeutics Public LTD CO Transaction History

Prelude Capital Management, LLC

$1.85 Billion
Q1 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $2.69 Million - $3.14 Million	27,159 Added 24.99%	135,854 $15.7 Million
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $4.2 Million - $4.9 Million	-43,634 Reduced 28.64%	108,695 $11.2 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $8.54 Million - $9.03 Million	79,596 Added 109.44%	152,329 $16.6 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $3.95 Million - $7.2 Million	63,245 Added 666.58%	72,733 $8.28 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $607,170 - $872,524	-10,305 Reduced 52.06%	9,488 $587,000

Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $1.07 Million - $1.57 Million	13,478 Added 213.43%	19,793 $1.58 Million
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $545,742 - $693,450	6,315 New	6,315 $664,000
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $1.08 Million - $1.32 Million	-10,982 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $293,928 - $352,963	3,198 Added 41.08%	10,982 $1.2 Million
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $459,141 - $510,678	5,324 Added 216.42%	7,784 $729,000
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $234,165 - $311,264	-3,260 Reduced 56.99%	2,460 $226,000
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $383,240 - $482,710	5,720 New	5,720 $418,000
Q2 2020 Aug 14, 2020	SELL	$30.2 - $56.98 $325,193 - $613,560	-10,768 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$24.87 - $38.56 $267,800 - $415,214	10,768 New	10,768 $319,000
Q4 2019 Feb 14, 2020	SELL	$25.43 - $36.67 $4,679 - $6,747	-184 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$23.0 - $27.97 $4,232 - $5,146	184 New	184 $5,000

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account